Undifferentiated Pleomorphic Sarcoma Clinical Trials

31 clinical trials for Undifferentiated Pleomorphic Sarcoma across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors — RECRUITING · PHASE1
• A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg — RECRUITING · PHASE2
• Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas — RECRUITING · NA
• Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma — RECRUITING · PHASE2
• Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. — RECRUITING · PHASE2
• Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas — RECRUITING · PHASE2
• MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients — RECRUITING · PHASE2
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma — NOT_YET_RECRUITING · PHASE2
• Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications — TERMINATED · PHASE1
• Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma — TERMINATED · NA
• Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma — ACTIVE_NOT_RECRUITING · PHASE1
• Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients — COMPLETED · NA
• Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery — ACTIVE_NOT_RECRUITING · PHASE2
• CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma — COMPLETED · PHASE1
• A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas — COMPLETED · PHASE2
• Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas — COMPLETED · PHASE1
• Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma — NOT_YET_RECRUITING · NA
• Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma — WITHDRAWN · PHASE3
• A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) — COMPLETED · PHASE1
• ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma — OTHER · PHASE2
• Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma — COMPLETED · PHASE2
• Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas — NOT_YET_RECRUITING
• Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma — WITHDRAWN · PHASE2
• A Study of LY3435151 in Participants With Solid Tumors — TERMINATED · PHASE1
• A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas — WITHDRAWN · PHASE2
• Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas — OTHER · PHASE2
• Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall — OTHER · PHASE2
• Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma — OTHER · PHASE2
• ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1

Refine this search